Ameriprise Financial Inc Moderna, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 212,273 shares of MRNA stock, worth $8.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

212,273

Previous 289,364 26.64%

Holding current value

$8.4 Million

Previous $34.4 Million 58.71%

% of portfolio

0.0%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $4.91 Million - $9.65 Million	-77,091 Reduced 26.64%	212,273 $14.2 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $940,544 - $1.55 Million	-9,293 Reduced 3.11%	289,364 $34.4 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $46,014 - $62,222	-539 Reduced 0.18%	298,657 $31.8 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $190,735 - $286,555	2,744 Added 0.93%	299,196 $29.8 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $1.21 Million - $1.58 Million	12,504 Added 4.4%	296,452 $30.6 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $575,791 - $780,015	-4,859 Reduced 1.68%	283,948 $34.5 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $2.97 Million - $4.32 Million	21,924 Added 8.21%	288,807 $44.4 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $5.26 Million - $9.34 Million	44,468 Added 19.99%	266,883 $47.9 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $2.81 Million - $4.62 Million	-23,796 Reduced 9.66%	222,415 $26.3 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $4.3 Million - $6.48 Million	-36,707 Reduced 12.97%	246,211 $35.1 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $3.58 Million - $6.66 Million	-28,324 Reduced 9.1%	282,918 $47.6 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $15.6 Million - $25.4 Million	69,045 Added 28.51%	311,242 $75.4 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $11.4 Million - $24.8 Million	51,284 Added 26.86%	242,197 $93.2 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $1.83 Million - $3.31 Million	-14,067 Reduced 6.86%	190,913 $44.9 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $13.9 Million - $23.6 Million	-126,865 Reduced 38.23%	204,980 $26.9 Million
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $5.24 Million - $13.5 Million	79,756 Added 31.64%	331,845 $34.6 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $1.82 Million - $3.17 Million	-33,446 Reduced 11.71%	252,089 $17.8 Million
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $546,165 - $1.47 Million	-18,408 Reduced 6.06%	285,535 $18.3 Million
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $278,488 - $494,637	15,663 Added 5.43%	303,943 $9.1 Million
Q4 2019 Feb 14, 2020	SELL	$13.93 - $21.28 $1.63 Million - $2.48 Million	-116,758 Reduced 28.83%	288,280 $5.64 Million
Q3 2019 Nov 14, 2019	BUY	$12.26 - $18.07 $4.5 Million - $6.64 Million	367,198 Added 970.4%	405,038 $6.44 Million
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $518,408 - $1.07 Million	37,840 New	37,840 $555,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Moderna, Inc. Transaction History